Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Immunoprecise Antibodies Ltd IPA

ImmunoPrecise Antibodies Ltd is a supplier of custom antibodies to the research industry and industrial community. The company has aggregated its operations into one reportable segment, Antibody Production, and Related Services. It operates in three principal geographical areas - the United States of America, Canada, Europe, and others. The majority of its revenue is derived from the United... see more

NDAQ:IPA - Post Discussion

Immunoprecise Antibodies Ltd > IPA investors of note
View:
Post by GoldenArm on Dec 05, 2022 10:17am

IPA investors of note

From

https://www.marketbeat.com/instant-alerts/nasdaq-ipa-a-buy-or-sell-right-now-2022-12/

Most interesting from article

"Hedge funds have recently added to or reduced their stakes in the business. Dimensional Fund Advisors LP purchased a new stake in shares of ImmunoPrecise Antibodies during the first quarter valued at approximately $67,000. Gradient Capital Advisors LLC raised its holdings in ImmunoPrecise Antibodies by 34.0% during the 3rd quarter. Gradient Capital Advisors LLC now owns 26,808 shares of the company's stock valued at $107,000 after buying an additional 6,808 shares during the last quarter. Cibc World Market Inc. purchased a new stake in ImmunoPrecise Antibodies during the 2nd quarter valued at $183,000. Bank of America Corp DE grew its holdings in ImmunoPrecise Antibodies by 1,849.1% in the 1st quarter. Bank of America Corp DE now owns 57,517 shares of the company's stock worth $295,000 after acquiring an additional 54,566 shares during the last quarter. Finally, Bank of Montreal Can increased its position in shares of ImmunoPrecise Antibodies by 62.7% in the first quarter. Bank of Montreal Can now owns 140,454 shares of the company's stock valued at $718,000 after acquiring an additional 54,145 shares during the period. 5.51% of the stock is owned by institutional investors."
Be the first to comment on this post
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities